This review demonstrates enhanced seed health testing using advanced diagnostics and imaging technologies, suggesting improved food security outcomes.
Seed health testing is a cornerstone of global food security, yet traditional diagnostic workflows often struggle to balance speed, sensitivity, and regulatory confidence under low-prevalence and heterogeneous seed lot conditions. This review synthesizes recent advances in molecular diagnostics (PCR, qPCR, LAMP, and digital PCR), non-destructive imaging technologies (hyperspectral, X-ray, and thermal imaging), and data-driven analytical approaches for pathogen detection in seeds. Emphasis is placed on the practical integration of these tools within high-throughput, ISO/IEC 17025-compliant laboratory workflows, highlighting their respective strengths, limitations, and roles in risk-based decision-making. Comparative discussions address cost, sensitivity, turnaround time, and field deployability across diagnostic platforms, supported by crop- and pathogen-specific examples. Emerging approaches such as CRISPR-based biosensing, advanced sequencing, and imaging-assisted analytics are discussed in the context of validation, regulatory acceptance, and operational feasibility. By focusing on implementation rather than conceptual frameworks, this review provides a pragmatic reference for laboratories, regulators, and seed companies seeking to modernize seed health testing while safeguarding trade integrity and biosecurity.
No takes yet. Share an insight, caveat, or question.
Bugingo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: